Circulating Transforming Growth Factor-β1 Levels in Preeclamptic Women: a Meta-analysis

[1]  Mengqin Yuan,et al.  Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy , 2021, Frontiers in Immunology.

[2]  L. Garmire,et al.  Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness , 2021, Hypertension.

[3]  Guang Song,et al.  Gene polymorphism associated with TGF‐β1 and susceptibility to preeclampsia: A meta‐analysis and trial sequential analysis , 2021, The journal of obstetrics and gynaecology research.

[4]  A. Xiang,et al.  Systemic transcriptome comparison between early‐ And late‐onset pre‐eclampsia shows distinct pathology and novel biomarkers , 2020, Cell proliferation.

[5]  V. Garovic,et al.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis , 2020, Hypertension.

[6]  Zong-Lai Jiang,et al.  Platelet‐derived microvesicles promote endothelial progenitor cell proliferation in intimal injury by delivering TGF‐β1 , 2020, The FEBS journal.

[7]  Kirsten Wisner.  Gestational Hypertension and Preeclampsia. , 2019, MCN. The American journal of maternal child nursing.

[8]  J. Fuglsang,et al.  Platelet function in preeclampsia - a systematic review and meta-analysis. , 2019, Platelets.

[9]  S. Karumanchi,et al.  Preeclampsia: Pathophysiology, Challenges, and Perspectives , 2019 .

[10]  N. A. El-Boghdady,et al.  Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women. , 2019, Archives of biochemistry and biophysics.

[11]  Xiaojie Huang,et al.  Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia , 2019, Experimental & Molecular Medicine.

[12]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[13]  T. Kluz,et al.  Angiogenic factor screening in women with mild preeclampsia – New and significant proteins in plasma , 2017, Cytokine.

[14]  Rui Zhu,et al.  Maternal circulating levels of transforming growth factor‐β superfamily and its soluble receptors in hypertensive disorders of pregnancy , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[15]  Ming Li,et al.  Decreased frequency of peripheral blood CD8+CD25+FoxP3+regulatory T cells correlates with IL-33 levels in pre-eclampsia , 2017, Hypertension in pregnancy.

[16]  S. Brennecke,et al.  Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. , 2016, The New England journal of medicine.

[17]  Tiejun Tong,et al.  Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range , 2015, Statistical methods in medical research.

[18]  J. Espinoza,et al.  Maternal obesity and excess of fetal growth in pre‐eclampsia , 2014, BJOG : an international journal of obstetrics and gynaecology.

[19]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[20]  K. Joseph,et al.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. , 2013, American journal of obstetrics and gynecology.

[21]  R. Taheripanah,et al.  Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women. , 2012, Journal of reproductive immunology.

[22]  A. Szarka,et al.  Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array , 2010, BMC Immunology.

[23]  R. Kaaks,et al.  Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. , 2009, Journal of immunological methods.

[24]  S. Y. Park,et al.  Soluble endoglin and transforming growth factor‐β1 in women who subsequently developed preeclampsia , 2009, Prenatal diagnosis.

[25]  V. T. Borges,et al.  Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia. , 2008, Journal of reproductive immunology.

[26]  G. Kuchel,et al.  ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  P. Lev,et al.  Platelets possess functional TGF-β receptors and Smad2 protein , 2007 .

[28]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[29]  B. Geramizadeh,et al.  Transforming growth factor beta-1 influence on fetal allografts during pregnancy. , 2005, Transplantation proceedings.

[30]  A. Ludlow,et al.  Latent TGF‐β1 activation by platelets , 2004 .

[31]  S. Aydin,et al.  Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels , 2003, Acta obstetricia et gynecologica Scandinavica.

[32]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[33]  L. Magee,et al.  Subclassification of Preeclampsia , 2003, Hypertension in pregnancy.

[34]  M. Di Nisio,et al.  Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. , 2002, American journal of hypertension.

[35]  S. Djurovic,et al.  Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? , 2002, Placenta.

[36]  L. Hefler,et al.  Transforming growth factor‐beta 1 serum levels in pregnancy and pre‐eclampsia , 2002, Acta obstetricia et gynecologica Scandinavica.

[37]  T. Naicker,et al.  Transforming growth factor β 1 levels in platelet depleted plasma in African women with pre-eclampsia , 2002 .

[38]  J. Bartha,et al.  The relationships between leptin and inflammatory cytokines in women with pre‐eclampsia , 2001, BJOG : an international journal of obstetrics and gynaecology.

[39]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[40]  Y. Kishi,et al.  Transforming growth factor-beta(1) restores antiplatelet function of endothelial cells exposed to anoxia-reoxygenation injury. , 2000, Thrombosis research.

[41]  D. Grainger,et al.  TGF-β in blood: a complex problem , 2000 .

[42]  S. Djurovic,et al.  Plasma concentrations of Lp(a) lipoprotein and TGF‐β1 are altered in preeclampsia , 1997, Clinical genetics.

[43]  A. Gressner,et al.  Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. , 1997, Clinical chemistry.

[44]  ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. , 2019, Obstetrics and gynecology.

[45]  Xiao-juan Wang,et al.  [Changes of plasma uPA and TGF-beta1 in patients with preeclampsia]. , 2010, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[46]  P. Lev,et al.  Platelets possess functional TGF-beta receptors and Smad2 protein. , 2007, Platelets.

[47]  A. Ludlow,et al.  Latent TGF-beta1 activation by platelets. , 2004, Journal of cellular physiology.

[48]  T. Naicker,et al.  Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia. , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[49]  D. Grainger,et al.  TGF-beta in blood: a complex problem. , 2000, Cytokine & growth factor reviews.

[50]  T. Spector,et al.  Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.